Literature DB >> 170018

Noninvasive quantitation of myocardial infarction with technetium 99m pyrophosphate.

E H Botvinick, D Shames, H Lappin, J V Tyberg, R Townsend, W W Parmley.   

Abstract

We sought to quantitate infarct size using radioactive imaging techniques. Infarcts were created in closed chest dogs. Using a scintillation camera interfaced to a computer, infarct images were made in the anterior, left lateral, LAO, and RAO projections, 48 hours after infarction and 75 to 90 min following the intravenous injection of 15 mCi of Technetium 99m pyrophosphate (Tc-PYP). Images were computer enhanced and area was calibrated with a radioactive grid source of known dimensions. Image radioactivity was normalized for decay and dose corrected for body weight. Animals were sacrificed two hours following the injection Tc-PYP. Postmortem images were also computer enhanced and calibrated. Gross infarct area and weight were estimated and transmural biopsies were evaluated for Tc-PYP activity and analyzed for creatine phosphokinase (CPK) content. Contiguous biopsies were pathologically analyzed and graded. There was a negative correlation between tissue Tc-PYP activity and CPK content (r=0.89). Pathologic severity worsened with increased Tc-PYP activity and diminished CPK content. There was a good correlation between gross infarct area and image infarct area, both in vivo (r

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170018     DOI: 10.1161/01.cir.52.5.909

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Myocardial scintigraphy with infarct-avid tracers.

Authors:  B L Holman; J Wynne
Journal:  Cardiovasc Radiol       Date:  1979-09

2.  Intravenous myocardial imaging performed serially early and late after acute myocardial infarction.

Authors:  H R Schelbert; H Henning; H P Rigo; S Khullar; W L Ashburn; R A O'Rourke
Journal:  Eur J Nucl Med       Date:  1977-06-30

3.  Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.

Authors:  L M Buja; A J Tofe; P V Kulkarni; A Mukherjee; R W Parkey; M D Francis; F J Bonte; J T Willerson
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

4.  Assessment of diagnostic value of technetium-99m pyrophosphate myocardial scintigraphy in 80 patients with possible acute myocardial infarction.

Authors:  W F Walsh; H B Karunaratne; L Resnekov; H R Fill; P V Harper
Journal:  Br Heart J       Date:  1977-09

5.  Nonperfusion applications in nuclear cardiology: report of a task force of the American Society of Nuclear Cardiology.

Authors:  E G DePuey; S Port; F J Wackers; A Rozanski; E H Botvinick; M W Dae; N Tamaki
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

6.  Noninvasive radionuclide procedures for diagnosis and management of myocardial ischemia.

Authors:  R H Jones; S K Rerych; G E Newman; P M Scholz; W R Howe; H N Oldham; J K Goodrich; D C Sabiston
Journal:  World J Surg       Date:  1978-11       Impact factor: 3.352

7.  Cardiovascular nuclear medicine and intensive care.

Authors:  P J Ell; R M Donaldson
Journal:  Intensive Care Med       Date:  1978-07       Impact factor: 17.440

8.  Positive myocardial scintigraphy at the bedside--evaluation using a portable gamma camera.

Authors:  D S Dymond; P H Jarritt; K E Britton; D Langley; R A Spurrell
Journal:  Postgrad Med J       Date:  1978-10       Impact factor: 2.401

9.  Advantages of technetium pyrophosphate scintigraphy over plasma enzyme analysis in estimation of anterior myocardial infarct size.

Authors:  S Saltissi; P S Robinson; M M Webb-Peploe; D J Coltart; D N Croft
Journal:  Br Heart J       Date:  1981-02

10.  Evaluation of bedside myocardial scintigraphy with 201Tl in acute myocardial infarction.

Authors:  M Decramer; P Devos; M De Roo; J Piessens; H De Geest
Journal:  Eur J Nucl Med       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.